
It depends on the formulation and indication — a North Carolina NP may prescribe codeine only when the specific formulation falls within the NP's authorized controlled-substance schedules1 and the NP has active North Carolina NP approval with prescriptive authority, prescribes within population focus, education, certification, and competence, and has a collaborative practice agreement identifying the applicable controlled-substance authority, DEA registration, and a primary supervising physician with controlled-substance schedules equal to or greater than the NP's DEA registration. Codeine's DEA schedule varies by formulation and dose, so the prescribing analysis depends on the product.2
For Schedule II or Schedule III opioid/narcotic codeine products that are targeted controlled substances, North Carolina STOP Act rules may apply. Initial acute-pain prescriptions are generally capped at 5 days, or 7 days for immediate post-operative acute pain, with statutory exclusions for chronic pain, cancer care, hospice care, palliative care, and medication-assisted treatment for substance use disorder.3
When the STOP Act applies, the NP may also need to review the CSRS before initial prescribing and every subsequent three-month period while the drug remains part of care, unless an exception applies, including certain administered-in-care-setting situations or cancer-related, hospice, or palliative-care prescribing.4 North Carolina also requires meaningful, documented supervising-physician consultation for targeted controlled-substance prescribing in specified pain-management and ongoing prescribing contexts.5 North Carolina NPs also may not prescribe controlled substances for themselves, their supervising physician, immediate family members, household members, or intimate partners.